Quantcast
Moderna says waiving IP rights won't help increase vaccine supply - Metro US

Moderna says waiving IP rights won’t help increase vaccine supply

FILE PHOTO: COVID-19 vaccinations at pharmaceutical company Apotex in Toronto

(Reuters) – Moderna Inc said on Thursday that waiving intellectual property rights on COVID-19 vaccines will not help boost supply in 2021 or 2022, a day after U.S. President Joe Biden backed a proposed waiver that is aimed at giving poorer companies access.

(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

More from our Sister Sites